ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

MiR-124-3p mediates gastric cancer cell ferroptosis induced by an anti-cancer drug polyphyllin I

Zheng, Fang; Bi, Jian-Can; Wei, Yu-Yan; Wang, Yeshu; Zhang, Qunfang; Liang, Chun-Ling; Wu, Jianwei*; Dai, Zhenhua*广州中医药大学
Frontiers in Pharmacology2023-11-7DOI: 10.3389/fphar.2023.1285799
5阅读
引用收藏
分享

摘要

Background: Ferroptosis is an emerging type of regulated cell death and associated with antitumoral therapy, while some microRNAs have been shown to regulate the tumorigenesis and cancer progression. Meanwhile, polyphyllin I (PPI) has exhibited antitumoral effects by promoting cancer cell apoptosis and ferroptosis. However, it is unclear whether PPI induces cancer cell ferroptosis by regulating microRNAs.Methods: We used two gastric cancer cell lines (AGS and MKN-45) to set up a tumor model of the nude mice, which were then treated daily with PPI to measure the cancer growth in vitro and in vivo. Ferroptosis was measured using immunofluorescence staining and flow cytometric analysis according to levels of intracellular ROS, lipid ROS and ferrous ions. Moreover, NRF2 expression was measured by Western blotting. In some experiments, the mimics or inhibitors of miR-124-3p were used to further confirm its involvement in PPI-induced cancer cell ferroptosis.Results: Here we found that miR-124-3p mediated cancer ferroptosis and tumor repression induced by PPI since PPI increased miR-124-3p expression in gastric cancer cells and promoted their ferroptosis, whereas inhibition of miR-124-3p mostly abolished the effects of PPI on tumor growth, ferroptosis and NRF2 expression. Moreover, miR-124-3p mimics promoted cancer cell ferroptosis by downregulating NRF2 through directly targeting 3 '-UTR region of NRF2, confirming a role for miR-124-3p in regulating PPI-induced ferroptosis.Conclusion: PPI exerts its antitumoral effects on the gastric cancer by promoting cell ferroptosis via regulating miR-124-3p. Our findings have clinical implications for cancer chemotherapy.

学科与关键词

关键词
antitumor drugferroptosisgastric cancerMiR-124-3ppolyphyllin I
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2023-11-07
卷期
第 14 卷
页码
1285799
DOI
10.3389/fphar.2023.1285799
语言
ENGLISH
成果收录
SCIE
资助标注
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Guangzhou Municipal Science and Technology Bureau (202201020347 and 202102021001). [202201020347, 202102021001]; Guangzhou Municipal Science and Technology Bureau

作者

  • Z

    Zheng, Fang (第一作者)

    2 · guangzhou univ chinese med

  • B

    Bi, Jian-Can

查看全部 8 位作者收起作者
  • W

    Wei, Yu-Yan

    2 · guangzhou univ chinese med

  • W

    Wang, Yeshu

    2 · guangzhou univ chinese med

  • Z

    Zhang, Qunfang

    2 · guangzhou univ chinese med

  • L

    Liang, Chun-Ling

    2 · guangzhou univ chinese med

  • W

    Wu, Jianwei (通讯)

    2 · guangzhou univ chinese med

  • D

    Dai, Zhenhua (通讯)

    2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417